MRI and FDG-PET/CT imaging in gynecological malignancies: the radiation oncology perspective

被引：0
|
作者：
Fennell, Jamina [1 ,5 ]
Scholber, Jutta [1 ,5 ]
Grosu, Anca-L. [1 ,5 ]
Volegova-Neher, Natalja [1 ,5 ]
Henne, Karl [1 ,5 ]
Langer, Mathias [2 ,5 ]
Meyer, Philipp T. [3 ,5 ]
Gitsch, Gerald [4 ,5 ]
Bartl, Nico [1 ,5 ]
机构：
[1] Univ Med Ctr Freiburg, Dept Radiat Oncol, Robert Koch Str 3, D-79106 Freiburg, Germany
[2] Univ Med Ctr Freiburg, Dept Radiol, Freiburg, Germany
[3] Univ Med Ctr Freiburg, Dept Nucl Med, Freiburg, Germany
[4] Univ Med Ctr Freiburg, Dept Gynecol, Freiburg, Germany
[5] Partner Site Freiburg, German Canc Consortium DKTK, Freiburg, Germany
来源：
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 60卷 / 02期
关键词：
Genital neoplasms; female; Radiotherapy; Positron emission tomography; Magnetic resonance imaging; LYMPH-NODE METASTASIS; ENDOMETRIAL CANCER; CERVICAL-CANCER; MAGNETIC-RESONANCE; PREOPERATIVE ASSESSMENT; FOLLOW-UP; MYOMETRIAL INVASION; DIAGNOSTIC-ACCURACY; TUMOR VOLUME; CARCINOMA;
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
MRI and FDG-PET imaging plays an important role in diagnosis, monitoring and follow-up of gynecological cancer. The goal of this paper was to summarize data of the literature about sensitivity and specificity of MRI and FDG-PET/CT for detection of primary tumor, lymph nodes invasion and metastases in cervix and endometrial cancer and to discuss their implication for radiation treatment planning and monitoring.
引用
收藏
页码：117 / 123
页数：7
相关论文
共 50 条
  • [1] Application of FDG-PET/CT in radiation oncology
    Li, Jun
    Xiao, Ying
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [2] Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology
    Schmidt, G. P.
    Haug, A.
    Reiser, M. F.
    Rist, C.
    RADIOLOGE, 2010, 50 (04): : 329 - 338
  • [3] FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
    A Lakhani
    S Khan
    N Bharwani
    V Stewart
    A Rockall
    T Barwick
    S Khan
    Cancer Imaging, 15 (Suppl 1)
  • [4] FDG-PET/CT in oncology
    Krause, B. J.
    Beyer, T.
    Bockisch, A.
    Delbeke, D.
    Kotzerke, J.
    Minkov, V.
    Reiser, M.
    Willich, N.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (06): : 291 - 301
  • [5] Validation of FDG-PET/MR imaging in gynecological cancer compared to standard clinical FDG-PET/CT
    Lofgren, J.
    Loft, A.
    Berthelsen, A. K.
    Hansen, A. E.
    Keller, S. H.
    Holm, S.
    Hojgaard, L.
    Beyer, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S370 - S371
  • [6] Feasibility of Integrated PET/MRI and PET/CT Imaging for Gynecological Malignancies
    Schwartz, M.
    Gavane, S.
    Bou-Ayache, J.
    Kolev, V.
    Zakashanksy, K.
    Prasad-Hayes, M.
    Taouli, B.
    Chuang, L.
    Kostakoglu, L.
    GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 193 - 193
  • [7] Imaging of oesophageal cancer with FDG-PET/CT and MRI
    van Rossum, P. S. N.
    van Lier, A. L. H. M. W.
    Lips, I. M.
    Meijer, G. J.
    Reerink, O.
    van Vulpen, M.
    Lam, M. G. E. H.
    van Hillegersberg, R.
    Ruurda, J. P.
    CLINICAL RADIOLOGY, 2015, 70 (01) : 81 - 95
  • [8] The QIBA profile for quantitative FDG-PET/CT oncology imaging
    Kinahan, Paul
    Wahl, Richard
    Shao, Lingxiong
    Frank, Richard
    Perlman, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [9] FDG-PET/CT and SPECT/CT in oncology
    Kim, E. Edmund
    Yang, David J.
    Wong, Franklin C.
    CURRENT MEDICAL IMAGING, 2008, 4 (01) : 63 - 69
  • [10] FDG-PET imaging in hematological malignancies
    Valls, L.
    Badve, C.
    Avril, S.
    Herrmann, K.
    Faulhaber, P.
    O'Donnell, J.
    Avril, N.
    BLOOD REVIEWS, 2016, 30 (04) : 317 - 331
12345